Targeting the mTOR Signaling Pathway Utilizing Nanoparticles: A Critical Overview

Area of Science:

• Oncology
• Nanomedicine
• Molecular Biology

Background:

• Mammalian target of rapamycin (mTOR) signaling pathway proteins are frequently altered in cancer.
• Clinical mTOR inhibition has shown limited success in cancer treatment.
• Nanoparticle-based drug delivery offers a potential strategy for targeted mTOR inhibition in oncology.

Purpose of the Study:

• To critically analyze the current literature on nanoparticle-mediated mTOR signaling modulation.
• To explore the complexities of cellular responses to functionalized nanoparticles.
• To identify challenges in understanding the molecular mechanisms of nanoparticle effects on mTOR signaling.

Main Methods:

• Literature review and critical analysis of existing studies on nanoparticles and mTOR signaling.
• Examination of cellular responses to functionalized nanoparticles.
• Discussion of potential molecular mechanisms involved in nanoparticle-induced mTOR modulation.

Main Results:

• Nanoparticle-based mTOR targeted therapy presents an attractive option for cancer treatment.
• Cellular responses to functionalized nanoparticles are complex and multifaceted.
• Subcytotoxic doses of nanoparticles may induce subcellular changes involving mTORC1 signaling.

Conclusions:

• Understanding nanoparticle-mTOR interactions is key to developing novel nano-therapeutics.
• Further investigation into the mechanisms of nanoparticle-based mTOR modulation is needed.
• This research could pave the way for safer and more effective cancer nanomedicines.